stella
beta
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC — Stella
Recruiting
Back to Epithelial Ovarian Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang
View full record on ClinicalTrials.gov